Three Peaks Capital Management’s Boston Scientific BSX Stock Holding History

Three Peaks Capital Management’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-64,063	Closed	-$2.46M	–	92
2019 Q1	$2.46M	Sell	64,063 -9,737	-13%	-$372K	0.72%	79
2018 Q4	$2.61M	Sell	73,800 -628	-0.8%	-$22.8K	0.82%	59
2018 Q3	$2.87M	Sell	74,428 -9,512	-11%	-$332K	0.59%	84
2018 Q2	$2.75M	Buy	+83,940	New	+$2.53M	0.55%	86

Other funds holding BSX

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Bollard Group Boston, Massachusetts $3.39B AUM 1.06% 1-Year Est. Return

Three Peaks Capital Management's BSX Position: Q2 2019 in Review

Three Peaks Capital Management sold out of Boston Scientific (BSX) in Q2 2019, closing a stake of 64,063 shares — an estimated $2.46M sold.

Three Peaks Capital Management first reported a position in BSX in Q2 2018 and held it in 4 quarters. The position peaked at $2.87M in Q3 2018. 757 funds tracked by Wall St. Rank hold BSX as of Q2 2019.

Three Peaks Capital Management reported no remaining Boston Scientific position as of Q2 2019 after selling out during the quarter.
Three Peaks Capital Management sold 64,063 Boston Scientific shares in Q2 2019, an estimated $2.46M.
Three Peaks Capital Management first reported a position in Boston Scientific in Q2 2018 and held it in 4 quarters.
Three Peaks Capital Management's Boston Scientific position peaked at $2.87M in Q3 2018.
757 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2019.

Based on Three Peaks Capital Management's 13F filing for Q2 2019, filed 6 Aug 2019.